The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA

Journal of Cell Biology - Tập 181 Số 6 - Trang 985-998 - 2008
Mika Sakurai‐Yageta1,2, Chiara Recchi1,2, Gaëlle Le Dez1,2, Jean‐Baptiste Sibarita1,2, Laurent Daviet3, Jacques Camonis1,4, Crislyn D’Souza‐Schorey5,6, Philippe Chavrier1,2
11Institut Curie, Centre de Recherche, Paris F-75248, France
22Centre National de la Recherche Scientifique, Unite Mixte Recherche 144, Paris F-75248, France
33Hybrigenics SA, Paris F-75014, France
44Institut National de la Santé et de la Recherche Médicale, Unite 528, Paris F-75248, France
55Department of Biological Sciences
66Walther Cancer Research Center, University of Notre Dame, Notre Dame, IN 46556

Tóm tắt

Invadopodia are actin-based membrane protrusions formed at contact sites between invasive tumor cells and the extracellular matrix with matrix proteolytic activity. Actin regulatory proteins participate in invadopodia formation, whereas matrix degradation requires metalloproteinases (MMPs) targeted to invadopodia. In this study, we show that the vesicle-tethering exocyst complex is required for matrix proteolysis and invasion of breast carcinoma cells. We demonstrate that the exocyst subunits Sec3 and Sec8 interact with the polarity protein IQGAP1 and that this interaction is triggered by active Cdc42 and RhoA, which are essential for matrix degradation. Interaction between IQGAP1 and the exocyst is necessary for invadopodia activity because enhancement of matrix degradation induced by the expression of IQGAP1 is lost upon deletion of the exocyst-binding site. We further show that the exocyst and IQGAP1 are required for the accumulation of cell surface membrane type 1 MMP at invadopodia. Based on these results, we propose that invadopodia function in tumor cells relies on the coordination of cytoskeletal assembly and exocytosis downstream of Rho guanosine triphosphatases.

Từ khóa


Tài liệu tham khảo

2006, Cancer Res., 66, 3034, 10.1158/0008-5472.CAN-05-2177

2004, J. Cell Biol., 166, 317, 10.1083/jcb.200312168

2006, Trends Cell Biol., 16, 242, 10.1016/j.tcb.2006.03.002

2004, Nat. Rev. Mol. Cell Biol., 5, 647, 10.1038/nrm1436

1999, Ann. NY Acad. Sci., 878, 361, 10.1111/j.1749-6632.1999.tb07695.x

1999, Int. J. Cancer., 82, 208, 10.1002/(SICI)1097-0215(19990719)82:2<208::AID-IJC10>3.0.CO;2-9

2000, Nature., 406, 532, 10.1038/35020106

2007, Cancer Res., 67, 4227, 10.1158/0008-5472.CAN-06-3928

2006, Cancer Metastasis Rev., 25, 9, 10.1007/s10555-006-7886-9

2003, J. Cell Biol., 163, 351, 10.1083/jcb.200309020

2005, Genome Res., 15, 376, 10.1101/gr.2659105

2003, Nat. Rev. Cancer., 3, 362, 10.1038/nrc1075

2002, Br. J. Cancer., 87, 635, 10.1038/sj.bjc.6600510

1997, J. Biol. Chem., 272, 29579, 10.1074/jbc.272.47.29579

2002, Cell., 109, 873, 10.1016/S0092-8674(02)00800-0

1998, Cell., 93, 731, 10.1016/S0092-8674(00)81435-X

2001, Nat. Cell Biol., 3, 353, 10.1038/35070029

2004, Proc. Natl. Acad. Sci. USA., 101, 6647, 10.1073/pnas.0401753101

2006, Genes Dev., 20, 2673, 10.1101/gad.1451806

2004, Int. Rev. Cytol., 233, 243, 10.1016/S0074-7696(04)33006-8

2006, J. Cell. Physiol., 206, 1, 10.1002/jcp.20431

2008, J. Biol. Chem., 283, 1008, 10.1074/jbc.M708466200

2001, Proc. Natl. Acad. Sci. USA., 98, 13693, 10.1073/pnas.241293698

2006, Eur. J. Cell Biol., 85, 195, 10.1016/j.ejcb.2005.09.008

2000, Mol. Cell. Biol., 20, 1030, 10.1128/MCB.20.3.1030-1043.2000

2006, Mol. Biol. Cell., 17, 2811, 10.1091/mbc.e05-11-1010

2006, J. Biol. Chem., 281, 6826, 10.1074/jbc.M513084200

2005, Dev. Cell., 9, 355

2007, J. Biol. Chem., 282, 426, 10.1074/jbc.M607711200

2003, Trends Cell Biol., 13, 376, 10.1016/S0962-8924(03)00128-4

2003, J. Biol. Chem., 278, 41237, 10.1074/jbc.M304838200

2001, Proc. Natl. Acad. Sci. USA., 98, 9648, 10.1073/pnas.171317898

2004, Front. Biosci., 9, 1944, 10.2741/1348

1993, Cancer Res., 53, 3159

1999, J. Biol. Chem., 274, 24947, 10.1074/jbc.274.35.24947

2006, Nat. Struct. Mol. Biol., 13, 577, 10.1038/nsmb1097

2002, Cancer Lett., 176, 101, 10.1016/S0304-3835(01)00742-X

2003, Genes Cells., 8, 1019, 10.1111/j.1365-2443.2003.00695.x

2005, J. Cell Sci., 118, 2085, 10.1242/jcs.02379

2002, J. Cell Biol., 159, 601, 10.1083/jcb.200205084

2005, Mol. Ther., 11, 267, 10.1016/j.ymthe.2004.08.029

2003, J. Cell Biol., 163, 1111, 10.1083/jcb.200305029

2003, J. Cell Sci., 116, 3905, 10.1242/jcs.00710

2005, J. Biol. Chem., 280, 34548, 10.1074/jbc.M507321200

2000, Methods Enzymol., 325, 264, 10.1016/S0076-6879(00)25448-7

2006, Mol. Cell. Biol., 26, 727, 10.1128/MCB.26.2.727-734.2006

2004, J. Cell Biol., 167, 769, 10.1083/jcb.200408028

2005, Curr. Opin. Genet. Dev., 15, 87, 10.1016/j.gde.2004.12.002

2002, Nat. Rev. Cancer., 2, 133, 10.1038/nrc725

2002, Nat. Cell Biol., 4, 73, 10.1038/ncb720

2004, Proc. Natl. Acad. Sci. USA., 101, 9671, 10.1073/pnas.0403531101

1996, EMBO J., 15, 6483, 10.1002/j.1460-2075.1996.tb01039.x

2003, Oncogene., 22, 8716, 10.1038/sj.onc.1206962

2001, J. Cell Biol., 155, 1345, 10.1083/jcb.200108112

2004, Dev. Cell., 7, 871, 10.1016/j.devcel.2004.10.017

2005, Dev. Cell., 9, 185, 10.1016/j.devcel.2005.06.006

2006, Curr. Biol., 16, 1515, 10.1016/j.cub.2006.05.065

2005, J. Cell Biol., 168, 441, 10.1083/jcb.200407076

2005, Curr. Opin. Cell Biol., 17, 559, 10.1016/j.ceb.2005.08.002

2001, J. Biol. Chem., 276, 46745, 10.1074/jbc.M107464200

2002, Lab. Invest., 82, 1673, 10.1097/01.LAB.0000041713.74852.2A